| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |